BRENT FIKES: Open Payments
NPI 1609165364 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 12 payments from 10 companies in 2025. Trend: 2023 $47 · 2024 $81 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $2 |
Products named: AIRSUPRA, PAXLOVID, WaveWriter Alpha Prime 16, DUPIXENT, TREMFYA, RELISTOR, RINVOQ, OCALIVA.
Industry payments across AR — which companies pay providers there.
